Companies / Italy
Italian Drug Agency Approves Orphan Disease Research
March 2006 | Company Finance AlertThe Italian drug regulatory agency - the AIFA - has approved funding for 54 study protocols into the areas of orphan and neglected disease medicines.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
